Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Bulls, pills and patents

Article Abstract:

Seprecor takes patent-expired drugs that were unsuccessful because of side-effects and finds ways to separate out the agents that cause the side-effects and then resells the drug to pharmaceutical companies. Some say he is creating new, useful drugs out of old ones, others accuse him of piracy.

Publisher: Economist Newspaper Ltd.
Publication Name: The Economist (UK)
Subject: Business, international
ISSN: 0013-0613
Year: 1997
Pharmaceutical Preparations, Drugs, Column, Complications and side effects, Sepracor Inc., Adverse drug reactions, SEPR

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


More than skin deep

Article Abstract:

A growing number of pharmaceutical firms are trying to develop transdermal drugs, to meet the expected rise in demand for such drugs. Transdermal technology means drugs can be given in a painless, controlled fashion.

Publisher: Economist Newspaper Ltd.
Publication Name: The Economist (UK)
Subject: Business, international
ISSN: 0013-0613
Year: 2001
Transdermal Drug Delivery Sys, Transdermal medication, Transdermal drug delivery systems

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Product development, Pharmaceutical industry
Similar abstracts:
  • Abstracts: Jobless and joyless. Over the rainbow
  • Abstracts: Truth is a pathles land. Gold standard: Cannes Film Festival
  • Abstracts: Ducati plans IPO and placement. Suzuki, Kawasaki team up. Suzuki to team up with Kawasaki to make bikes
  • Abstracts: Roboshop: intelligent agents. Marked by the market. Agility counts
  • Abstracts: Science and sensibility. Brothers in arms. Rocket science
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2023 Advameg, Inc.